Beyond the Sales Pitch
Marketing materials and sales conversations tend to present a manufacturer’s capabilities in their best light, which is expected but means buyers need independent ways to verify technical capability rather than relying solely on claims made during commercial discussions. Asking to speak directly with technical or R&D staff, separate from the sales team, is a reasonable request and one that capable manufacturers generally accommodate without difficulty.
The specificity and technical fluency of answers to detailed process questions, such as how the manufacturer handles a particular difficult amino acid or what its typical coupling efficiency is for a given sequence type, is often more revealing than any general capability statement.
Evaluating Synthesis and Analytical Equipment
A manufacturer’s equipment list, including synthesizer type and scale, HPLC and mass spectrometry instrumentation, and lyophilization capacity, gives a concrete basis for assessing whether its infrastructure matches your project’s requirements. Buyers should ask not just what equipment exists but its condition, maintenance schedule, and typical utilization, since older or poorly maintained equipment can affect both quality consistency and available capacity.
For sequences with unusual characteristics, such as very hydrophobic or aggregation-prone peptides, asking whether the manufacturer has specific experience or specialized equipment for that category is more informative than general capability claims.
Reviewing Past Project Complexity
Rather than asking only about years in business, ask about the range of sequence complexity and scale the manufacturer has successfully handled, ideally with specific, even if anonymized, examples relevant to your project’s difficulty level. A manufacturer with extensive experience in simple, short peptides may not have proven capability for a complex, modified, or very long sequence, even if it markets broadly as a peptide manufacturer.
Requesting example chromatograms or process summaries for a comparable past project, under confidentiality if needed, provides tangible evidence of capability that general claims cannot substitute for.
Piloting Before Committing to Full Scale
For buyers uncertain about a manufacturer’s capability with a specific sequence, commissioning a small feasibility or pilot batch before committing to a full production order is a reasonable and common way to de-risk the relationship. This approach costs more upfront than committing directly to full scale but substantially reduces the risk of discovering capability gaps only after a large order has already been placed.
A manufacturer’s willingness to offer this kind of staged engagement, rather than insisting on full commitment upfront, is itself a positive signal about the manufacturer’s confidence in its own process and willingness to work collaboratively with new clients.